Objective: To determine the effects of Ginkgo leaf concentrated oral liquor (GLC) on airway inflammation.Methods: Airway hyperreactivity, clinical symptoms and pulmonary functions of asthma patients were determined.Results: In contrast to placebo group, GLC significantly reduced airway hyperreactivity (P< 0.05) and improved clinical symptoms (P<0.05) and pulmonary functions (P<0.05) of the asthmatic patients.Conclusion: GLC is an effective drug of anti-airway inflammation.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
1990; 17(6): 258–262.
PAF 1990;13 (4): 197–201.
Barnes PJ. PAF and asthma. J Allergy Clin Immunol 1988; 81: 152–159.
About this article
Cite this article
Li, M., Yang, B., Yu, H. et al. Clinical observation of the therapeutic effect of Ginkgo leaf concentrated oral liquor on bronchial asthma. CJIM 3, 264–267 (1997). https://doi.org/10.1007/BF02934827
- Ginkgo leaf concentrated oral liquor
- airway hyperreactivity
- pulmonary function